Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Non-cash Items (2016)

Avalo Therapeutics (AVTX) has disclosed Non-cash Items for 2 consecutive years, with $657099.0 as the latest value for Q3 2016.

  • For the quarter ending Q3 2016, Non-cash Items rose 49.47% year-over-year to $657099.0, compared with a TTM value of $657099.0 through Sep 2016, up 49.47%, and an annual FY2015 reading of $604167.0, changed N/A over the prior year.
  • Non-cash Items was $657099.0 for Q3 2016 at Avalo Therapeutics, up from $642541.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $657099.0 in Q3 2016 and bottomed at $439607.0 in Q3 2015.